While there are currently no clinical trials evaluating the safety and efficacy of the AHR inhibitors for the treatment of viral infections, recent trials tested the AHR inhibitors IK-175 [33] and BAY 2416964 [34] for the treatment of solid tumors. The gene discussed is AHR; the disease is viral infectious disease.